glp 1 nz New diabetes medicines funded: empagliflozin and dulaglutide Calocurb, the New Zealand-based company

The concerns about a potential link between GLP-1 receptor agonists and thyroid cancer largely stem from early animal studies

Benefits of BPC-157 Accelerated healing of tendons and ligaments Protection and repair of the gastrointestinal mucosa Anti-inflammatory effects in musculoskeletal injuries Potential support for muscle recovery and pain reduction Mechanism of Action BPC-157 appears to promote angiogenesis (new blood vessel formation) by upregulating growth factors such as VEGF

Specifically, it produces no IGF-1 elevation (avoiding proliferative concerns), no negative impact on glucose metabolism (avoiding diabetes risk), no fluid retention or edema, and no concerning patterns of joint pain that can occur with growth hormone

The frequency of your injections depends on your individual needs

Cardiovasc Res 49 (4), 798807

Oral B12 is usually taken daily at 1,000 to 2,000 mcg